Search research articles
Contact Us
Filters
Showing results (81-90 of 466) with videos related to
Page
of 47
Sort By:
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
April 26, 2006
Antagonizing inactivated tumor suppressor genes and activated oncogenes by a versatile transgenesis system: application in mantle cell lymphoma
Armin Pscherer, Julia Schliwka, Kathrin Wildenberger, et al.
Haematologica
|
November 17, 2018
<i>TP53</i> aberrations in chronic lymphocytic leukemia: an overview of the clinical implications of improved diagnostics
Elias Campo, Florence Cymbalista, Paolo Ghia, et al.
Blood
|
December 13, 2003
The prognostic impact of autologous stem cell transplantation in patients with chronic lymphocytic leukemia: a risk-matched analysis based on the VH gene mutational status
Peter Dreger, Stephan Stilgenbauer, Axel Benner, et al.
Leukemia & Lymphoma
|
July 16, 2013
Extracellular vesicles in chronic lymphocytic leukemia
Franziska Haderk, Bola Hanna, Karsten Richter, et al.
Leukemia & Lymphoma
|
November 4, 2009
BCL2-938C>A polymorphism and disease progression in chronic lymphocytic leukemia
Thorsten Zenz, Axel Benner, Ulrich Dührsen, et al.
Molecular and Clinical Oncology
|
December 15, 2021
Cost-effectiveness of precision cancer medicine-current challenges in the use of next generation sequencing for comprehensive tumour genomic profiling and the role of clinical utility frameworks (Review)
Konstantinos Christofyllakis, Joerg Thomas Bittenbring, Lorenz Thurner, et al.
Leukemia & Lymphoma
|
October 24, 2012
BRAF mutations in chronic lymphocytic leukemia
Billy Michael Chelliah Jebaraj, Dirk Kienle, Andreas Bühler, et al.
Blood
|
August 1, 2002
V(H) mutation status, CD38 expression level, genomic aberrations, and survival in chronic lymphocytic leukemia
Alexander Kröber, Till Seiler, Axel Benner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 2, 2004
Microarray gene expression profiling of B-cell chronic lymphocytic leukemia subgroups defined by genomic aberrations and VH mutation status
Christian Haslinger, Norbert Schweifer, Stephan Stilgenbauer, et al.
British Journal of Haematology
|
December 8, 2009
Lenalidomide treatment of chronic lymphocytic leukaemia patients reduces regulatory T cells and induces Th17 T helper cells
Irina Idler, Krzysztof Giannopoulos, Thorsten Zenz, et al.
Page
of 47
Search research articles
Search
Showing results (81-90 of 466) with videos related to
Sort By:
Page
of 47
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
April 26, 2006
Antagonizing inactivated tumor suppressor genes and activated oncogenes by a versatile transgenesis system: application in mantle cell lymphoma
Armin Pscherer, Julia Schliwka, Kathrin Wildenberger, et al.
Haematologica
|
November 17, 2018
<i>TP53</i> aberrations in chronic lymphocytic leukemia: an overview of the clinical implications of improved diagnostics
Elias Campo, Florence Cymbalista, Paolo Ghia, et al.
Blood
|
December 13, 2003
The prognostic impact of autologous stem cell transplantation in patients with chronic lymphocytic leukemia: a risk-matched analysis based on the VH gene mutational status
Peter Dreger, Stephan Stilgenbauer, Axel Benner, et al.
Leukemia & Lymphoma
|
July 16, 2013
Extracellular vesicles in chronic lymphocytic leukemia
Franziska Haderk, Bola Hanna, Karsten Richter, et al.
Leukemia & Lymphoma
|
November 4, 2009
BCL2-938C>A polymorphism and disease progression in chronic lymphocytic leukemia
Thorsten Zenz, Axel Benner, Ulrich Dührsen, et al.
Molecular and Clinical Oncology
|
December 15, 2021
Cost-effectiveness of precision cancer medicine-current challenges in the use of next generation sequencing for comprehensive tumour genomic profiling and the role of clinical utility frameworks (Review)
Konstantinos Christofyllakis, Joerg Thomas Bittenbring, Lorenz Thurner, et al.
Leukemia & Lymphoma
|
October 24, 2012
BRAF mutations in chronic lymphocytic leukemia
Billy Michael Chelliah Jebaraj, Dirk Kienle, Andreas Bühler, et al.
Blood
|
August 1, 2002
V(H) mutation status, CD38 expression level, genomic aberrations, and survival in chronic lymphocytic leukemia
Alexander Kröber, Till Seiler, Axel Benner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 2, 2004
Microarray gene expression profiling of B-cell chronic lymphocytic leukemia subgroups defined by genomic aberrations and VH mutation status
Christian Haslinger, Norbert Schweifer, Stephan Stilgenbauer, et al.
British Journal of Haematology
|
December 8, 2009
Lenalidomide treatment of chronic lymphocytic leukaemia patients reduces regulatory T cells and induces Th17 T helper cells
Irina Idler, Krzysztof Giannopoulos, Thorsten Zenz, et al.
Page
of 47